BR112013028251A2 - polipeptídeo - Google Patents

polipeptídeo

Info

Publication number
BR112013028251A2
BR112013028251A2 BR112013028251A BR112013028251A BR112013028251A2 BR 112013028251 A2 BR112013028251 A2 BR 112013028251A2 BR 112013028251 A BR112013028251 A BR 112013028251A BR 112013028251 A BR112013028251 A BR 112013028251A BR 112013028251 A2 BR112013028251 A2 BR 112013028251A2
Authority
BR
Brazil
Prior art keywords
polypeptide
avaible
abstract
Prior art date
Application number
BR112013028251A
Other languages
English (en)
Other versions
BR112013028251B1 (pt
Inventor
Fritz Eitchenseher
Martin Johannes Loessner
Original Assignee
Micreos Human Health Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44626456&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112013028251(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Micreos Human Health Bv filed Critical Micreos Human Health Bv
Publication of BR112013028251A2 publication Critical patent/BR112013028251A2/pt
Publication of BR112013028251B1 publication Critical patent/BR112013028251B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2462—Lysozyme (3.2.1.17)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56938—Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

abstract not avaible
BR112013028251-7A 2011-05-04 2011-05-04 Polipeptídeos, nucleotídeos que codificam os mesmos, composições, métodos de produção e usos dos mesmos BR112013028251B1 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/NL2011/050307 WO2012150858A1 (en) 2011-05-04 2011-05-04 A polypeptide

Publications (2)

Publication Number Publication Date
BR112013028251A2 true BR112013028251A2 (pt) 2017-01-17
BR112013028251B1 BR112013028251B1 (pt) 2021-04-06

Family

ID=44626456

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013028251-7A BR112013028251B1 (pt) 2011-05-04 2011-05-04 Polipeptídeos, nucleotídeos que codificam os mesmos, composições, métodos de produção e usos dos mesmos

Country Status (15)

Country Link
US (2) US9382298B2 (pt)
EP (2) EP3085777B1 (pt)
JP (1) JP6261086B2 (pt)
KR (1) KR101911114B1 (pt)
CN (2) CN108192902A (pt)
AU (1) AU2011367262B2 (pt)
BR (1) BR112013028251B1 (pt)
CA (1) CA2834924C (pt)
DK (2) DK2705144T4 (pt)
ES (2) ES2768777T3 (pt)
HK (1) HK1195791A1 (pt)
IL (1) IL229247B (pt)
PL (2) PL3085777T3 (pt)
SG (1) SG194776A1 (pt)
WO (1) WO2012150858A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9206411B2 (en) * 2012-06-13 2015-12-08 The United States Of America, As Represented By The Secretary Of Agriculture Staphylococcal Phage2638A endolysin amidase domain is lytic for Staphylococcus aureus
CA2917726A1 (en) * 2013-07-11 2015-01-15 Micreos Human Health B.V. Combination treatment for eczema comprising an anti-inflammatory compound and a compound specifically targeting a bacterial cell
JP7059003B2 (ja) * 2014-05-14 2022-04-25 トラスティーズ・オブ・ダートマス・カレッジ 脱免疫化リゾスタフィン及び使用方法
JP2018509415A (ja) 2015-03-12 2018-04-05 マイクレオス ヒューマン ヘルス ビー．ブイ．Ｍｉｃｒｅｏｓ Ｈｕｍａｎ Ｈｅａｌｔｈ Ｂ．Ｖ． 細菌感染の治療方法
DK3144387T3 (en) * 2015-09-15 2018-04-30 Micreos Human Health Bv New endolysin polypeptide
ES2941467T3 (es) 2017-10-06 2023-05-23 Micreos Human Health Bv Tratamiento de una enfermedad asociada a la infección por una bacteria oncogénica
CA3092109A1 (en) * 2018-02-26 2019-08-29 Contrafect Corporation Modified plyss2 lysins and uses thereof
JP7454211B2 (ja) 2020-01-20 2024-03-22 日本全薬工業株式会社 バクテリオファージ由来エンドライシン
AU2021238683A1 (en) 2020-03-19 2022-10-13 Micreos Human Health B.V. A stabilized protein of interest
WO2021213898A1 (en) * 2020-04-20 2021-10-28 Micreos Human Health B.V. A chimeric endolysin polypeptide.
WO2023049243A1 (en) * 2021-09-22 2023-03-30 Biomedit, Llc Lysostaphin variants and methods of use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO2185699T3 (pt) * 2007-08-22 2018-04-21
ES2627321T3 (es) * 2008-07-03 2017-07-27 The Rockefeller University Una lisina de bacteriófago quimérica con actividad contra bacterias estafilocócicas
WO2010011960A2 (en) 2008-07-24 2010-01-28 The United State Of America, As Represented By The Secretary Of Agriculture Triple acting antimicrobials that are refractory to resistance development
EP2157100A1 (en) 2008-08-19 2010-02-24 Profos AG Artificial peptidoglycan lysing enzymes and peptidoglycan binding proteins
DK2563916T3 (en) * 2010-04-27 2015-10-05 Lysando Ag METHOD FOR REDUCING biofilms
WO2012146738A1 (en) 2011-04-27 2012-11-01 Lysando Holding Ag New antimicrobial agents

Also Published As

Publication number Publication date
DK3085777T3 (da) 2020-02-03
EP2705144B2 (en) 2019-08-28
ES2589784T3 (es) 2016-11-16
AU2011367262B2 (en) 2016-11-03
CA2834924C (en) 2022-08-16
AU2011367262A1 (en) 2013-11-21
KR20140066976A (ko) 2014-06-03
ES2589784T5 (es) 2020-04-21
EP3085777B1 (en) 2019-11-06
EP3085777A1 (en) 2016-10-26
US10174300B2 (en) 2019-01-08
ES2768777T3 (es) 2020-06-23
IL229247A0 (en) 2014-01-30
EP2705144B1 (en) 2016-06-08
IL229247B (en) 2019-03-31
US20140127168A1 (en) 2014-05-08
PL2705144T3 (pl) 2016-12-30
HK1195791A1 (zh) 2014-11-21
US20160369255A1 (en) 2016-12-22
DK2705144T4 (da) 2019-10-21
BR112013028251B1 (pt) 2021-04-06
EP2705144A1 (en) 2014-03-12
US9382298B2 (en) 2016-07-05
CN108192902A (zh) 2018-06-22
CA2834924A1 (en) 2012-11-08
KR101911114B1 (ko) 2018-10-23
JP2014519815A (ja) 2014-08-21
JP6261086B2 (ja) 2018-01-17
SG194776A1 (en) 2013-12-30
WO2012150858A1 (en) 2012-11-08
PL3085777T3 (pl) 2020-05-18
CN103703127A (zh) 2014-04-02
DK2705144T3 (da) 2016-09-05

Similar Documents

Publication Publication Date Title
BR112013028235A2 (pt) refrigerador
BR112013028512A2 (pt) cápsula
UY34456A (es) Anticuerpos anti-il-36r
UY34206A (es) Anticuerpo monoclonal de interleucina-31
BR112014001219A2 (pt) perfume
BR112013028251A2 (pt) polipeptídeo
UY4175Q (es) Reloj pulsera
CO6900146A2 (es) Imidazopiridazinas sustituidas con amino
BR112013025755A2 (pt) aparelho de guincho
BR112014004902A2 (pt) peptídeos
BR112014002403A2 (pt) composição dentifrícia não aquosa
UY34644A (es) Polipéptidos de unión a cx3cr1
BR112013024211A2 (pt) tratamento de tumores sólidos
BR112013028039A2 (pt) composição de cimento
BR112013025866A2 (pt) formulações com viscosidade reduzida
FR2988733B1 (fr) Microorganisme recombinant
BR112014026634A2 (pt) direcionador
BR112013026462A2 (pt) protetor de pé
BR112013029784A2 (pt) bomba
BR112013032555A2 (pt) composição selante híbrida
BR112014027219A2 (pt) método
BR112013032536A2 (pt) módulo de conexão elétrica
BR112013027727A2 (pt) dispositivo de ciclagem
UY34483A (es) Polipeptido
BR112013026604A2 (pt) disposição de intertravamento de painel

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B09W Correction of the decision to grant [chapter 9.1.4 patent gazette]

Free format text: O PRESENTE PEDIDO TEVE UM PARECER DE DEFERIMENTO NOTIFICADO NA RPI NO 2613 DE 02/02/2021, TENDO SIDO CONSTATADO QUE ESTA NOTIFICACAO FOI EFETUADA COM INCORRECOES NO TITULO DO RELATORIO DE EXAME TECNICO E NO QUADRO 1 DO PARECER DE DEFERIMENTO.

B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 04/05/2011, OBSERVADAS AS CONDICOES LEGAIS.